| Gland Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 16.47 | 16.47 | 16.43 | 16.36 | 15.50 |
| Reserves | 8,978.82 | 7,936.83 | 7,141.72 | 5,886.93 | 3,630.74 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 |
| Total Shareholders Funds | 8,995.29 | 7,953.30 | 7,158.23 | 5,903.29 | 3,646.24 |
| Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured Loans | 3.66 | 4.45 | 4.74 | 5.00 | 4.96 |
| Total Debt | 3.66 | 4.45 | 4.74 | 5.00 | 4.96 |
| Other Liabilities | 20.69 | 1.73 | 1.73 | 1.73 | 2.66 |
| Total Liabilities | 9,019.64 | 7,959.48 | 7,164.70 | 5,910.02 | 3,653.86 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 2,579.91 | 2,294.96 | 2,081.32 | 1,430.70 | 1,347.81 |
| Less: Accumulated Depreciation | 886.18 | 724.41 | 579.13 | 476.47 | 379.71 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 1,693.73 | 1,570.55 | 1,502.19 | 954.23 | 968.10 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 120.01 | 177.22 | 190.75 | 337.81 | 188.47 |
| Investments | 2,385.74 | 8.16 | 163.03 | 0.55 | 0.00 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,260.21 | 1,945.30 | 1,185.67 | 1,275.17 | 756.28 |
| Sundry Debtors | 1,171.40 | 862.84 | 1,074.81 | 670.97 | 601.79 |
| Cash and Bank Balance | 1,598.55 | 3,767.00 | 3,085.80 | 3,005.20 | 1,325.19 |
| Loans and Advances | 541.17 | 313.20 | 343.30 | 171.73 | 163.03 |
| Total Current Assets | 4,571.32 | 6,888.34 | 5,689.57 | 5,123.07 | 2,846.29 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 381.12 | 698.17 | 538.93 | 458.34 | 329.93 |
| Provisions | 32.07 | 31.32 | 42.75 | 53.82 | 28.20 |
| Total CL & Provisions | 413.19 | 729.49 | 581.68 | 512.16 | 358.13 |
| Net Current Assets | 4,158.14 | 6,158.85 | 5,107.89 | 4,610.90 | 2,488.15 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 8.28 | 22.71 | 7.65 | 6.02 | 6.05 |
| Deferred Tax Liability | 116.54 | 106.92 | 95.41 | 79.90 | 80.10 |
| Net Deferred Tax | -108.26 | -84.21 | -87.76 | -73.88 | -74.05 |
| Other Assets | 770.30 | 128.92 | 288.60 | 80.40 | 83.18 |
| Total Assets | 9,019.65 | 7,959.48 | 7,164.70 | 5,910.01 | 3,653.85 |
| Contingent Liabilities | 15.58 | 22.07 | 12.76 | 74.70 | 11.83 |